Pfizer Q3 Beats Expectations, Raises 2026 Outlook & Appoints New CFOPfizer’s Q3 earnings beat, boosted oncology outlook, and new CFO signal a comeback—high‑growth yet pricey, worth watching for savvy investors.PFIZER INC Health Care Pharmaceuticals, Biotechnology & Life Sciences AI generated 05/11/2026, 16:21 3 minutes to read